[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EE200200103A - Mesoprogestiinid (progesterooniretseptori modulaatorid) naise kontratseptiivide komponendina - Google Patents

Mesoprogestiinid (progesterooniretseptori modulaatorid) naise kontratseptiivide komponendina

Info

Publication number
EE200200103A
EE200200103A EEP200200103A EEP200200103A EE200200103A EE 200200103 A EE200200103 A EE 200200103A EE P200200103 A EEP200200103 A EE P200200103A EE P200200103 A EEP200200103 A EE P200200103A EE 200200103 A EE200200103 A EE 200200103A
Authority
EE
Estonia
Prior art keywords
mesoprogestins
component
receptor modulators
progesterone receptor
female contraceptives
Prior art date
Application number
EEP200200103A
Other languages
English (en)
Inventor
Chwalisz Kristof
Elger Walter
Schubert Gerd
Original Assignee
Jenapharm Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh & Co. Kg filed Critical Jenapharm Gmbh & Co. Kg
Publication of EE200200103A publication Critical patent/EE200200103A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200200103A 1999-08-31 2000-08-31 Mesoprogestiinid (progesterooniretseptori modulaatorid) naise kontratseptiivide komponendina EE200200103A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38613399A 1999-08-31 1999-08-31
PCT/IB2000/002053 WO2001026603A2 (en) 1999-08-31 2000-08-31 Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives

Publications (1)

Publication Number Publication Date
EE200200103A true EE200200103A (et) 2003-04-15

Family

ID=23524305

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200103A EE200200103A (et) 1999-08-31 2000-08-31 Mesoprogestiinid (progesterooniretseptori modulaatorid) naise kontratseptiivide komponendina

Country Status (28)

Country Link
EP (1) EP1605949A2 (et)
JP (1) JP2003511399A (et)
KR (1) KR20020038745A (et)
CN (1) CN1384748A (et)
AR (1) AR025455A1 (et)
AU (1) AU781835B2 (et)
BG (1) BG106441A (et)
BR (1) BR0013711A (et)
CA (1) CA2383650A1 (et)
CO (1) CO5190694A1 (et)
CZ (1) CZ2002707A3 (et)
EA (1) EA006805B1 (et)
EE (1) EE200200103A (et)
HR (1) HRP20020265A2 (et)
HU (1) HUP0202515A3 (et)
IL (1) IL148415A0 (et)
LT (1) LT5001B (et)
LV (1) LV12940B (et)
MX (1) MXPA02002186A (et)
NO (1) NO20020998L (et)
NZ (1) NZ517470A (et)
PE (1) PE20010579A1 (et)
PL (1) PL353994A1 (et)
SI (1) SI20853A (et)
SK (1) SK2982002A3 (et)
UA (1) UA77150C2 (et)
WO (1) WO2001026603A2 (et)
YU (1) YU13902A (et)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014935A1 (de) * 2002-08-02 2004-02-19 Schering Aktiengesellschaft Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
CA2524474A1 (en) * 2003-05-02 2004-11-18 Duramed Pharmaceuticals, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
US20050215535A1 (en) * 2004-03-24 2005-09-29 Kristof Chwalisz Sequential SPRM/progestin treatment
TW200603813A (en) * 2004-07-07 2006-02-01 Wyeth Corp Cyclic progestin regimens and kits
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
PT2419108T (pt) * 2009-04-14 2016-11-07 Hra Pharma Lab Método para contracepção quando necessária
CN110548034A (zh) * 2019-07-12 2019-12-10 广州莎蔓生物科技有限公司 一种怀孕阻断药物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054271A (en) 1932-05-17 1936-09-15 Schering Kahlbaum Ag Production of crystallized hormone esters
DE699310C (de) 1936-11-20 1940-11-27 Chemische Ind Ges Verfahren zur Herstellung von in 3-Stellung veresterten Verbindungen vom Typus des Oestradiols
US2225419A (en) 1937-03-01 1940-12-17 Schering Corp Process for the conversion of 17-cisalcohols of the cyclopentanopolyhydrophenanthrene series into the corresponding 17-trans-alcohols
US2611773A (en) 1951-08-21 1952-09-23 Upjohn Co Estradiol 17-cyclopenetanepropionate
US2990414A (en) 1957-03-26 1961-06-27 Syntex Sa 17-undecenoate of estradiol
DE3337450A1 (de) 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
EP0309263B1 (en) * 1987-09-24 1994-03-09 Jencap Research Limited Hormone composition and use
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
US5516769A (en) 1993-02-19 1996-05-14 The Medical College Of Hampton Roads Method of inhibiting fertilization
DE4332283A1 (de) 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332284C2 (de) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4429398C2 (de) 1994-08-09 1997-09-11 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption
DE4429397C2 (de) 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
PT787002E (pt) * 1994-10-24 2007-03-30 Schering Ag Antagonistas de progesterona competitivos para controlo de fertilidade feminina orientado pela necessidade
US6040340A (en) * 1996-05-07 2000-03-21 Schering Aktiengesellschaft Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors
DE69710896T2 (de) * 1996-06-25 2002-09-26 Akzo Nobel N.V., Arnhem Progestogen-anti-progestogen therapien
WO1998005679A2 (en) * 1996-08-05 1998-02-12 Duke University Mixed agonists of the progesterone receptor and assays therefor
DE19809845A1 (de) * 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
CA2371273A1 (en) * 1999-05-04 2000-11-09 Andrew Fensome Tetracyclic progesterone receptor modulator compounds and methods

Also Published As

Publication number Publication date
CA2383650A1 (en) 2001-04-19
NO20020998L (no) 2002-03-14
SK2982002A3 (en) 2002-07-02
AR025455A1 (es) 2002-11-27
PE20010579A1 (es) 2001-06-04
BR0013711A (pt) 2002-05-07
NZ517470A (en) 2004-03-26
EP1605949A2 (en) 2005-12-21
WO2001026603A2 (en) 2001-04-19
HRP20020265A2 (en) 2004-02-29
WO2001026603A3 (en) 2002-01-17
NO20020998D0 (no) 2002-02-28
KR20020038745A (ko) 2002-05-23
LT2002035A (lt) 2002-10-25
BG106441A (bg) 2002-09-30
YU13902A (sh) 2006-01-16
SI20853A (sl) 2002-10-31
EA200200284A1 (ru) 2002-10-31
CO5190694A1 (es) 2002-08-29
JP2003511399A (ja) 2003-03-25
UA77150C2 (en) 2006-11-15
PL353994A1 (en) 2003-12-15
EA006805B1 (ru) 2006-04-28
IL148415A0 (en) 2002-09-12
AU781835B2 (en) 2005-06-16
HUP0202515A3 (en) 2004-06-28
MXPA02002186A (es) 2002-09-02
AU3215001A (en) 2001-04-23
CZ2002707A3 (cs) 2002-11-13
LT5001B (lt) 2003-03-25
CN1384748A (zh) 2002-12-11
LV12940B (en) 2003-06-20
HUP0202515A2 (hu) 2002-12-28

Similar Documents

Publication Publication Date Title
NO20015272L (no) Glukokortikoid reseptor modulatorer
IL184642A0 (en) Process for the preparation of non-steroidal glucocorticoid receptor modulators
AU4686100A (en) Primary connector for pre-cast structures
DK1051179T3 (da) Anti-estrogen- plus progestin-holdige orale kontraceptiva
DK1140034T3 (da) Formulering af divalproex-natrium med kontrolleret frigivelse
EP1189597A4 (en) COMPOSITIONS USING AN OIL CORE FOR DELAYED RELEASE HYDROPHOLE MEDICAMENTS
IL154984A0 (en) Estrogen receptor modulators
EE200200103A (et) Mesoprogestiinid (progesterooniretseptori modulaatorid) naise kontratseptiivide komponendina
NO20021452L (no) Orale kontrollerte frigivelsesformuleringer
SG114650A1 (en) Cyclocarbamate derivatives as progesterone receptor modulators
GB9927215D0 (en) Hormone receptor expression
HK1043989A1 (zh) 作為黃體酮受體調節劑的環胺基甲酸鹽衍生物
HK1043789A1 (zh) 作為黃體酮受體調節劑的環硫代胺基甲酸鹽衍生物
HU0101874D0 (en) Enzymatic resolution of selective estrogen receptor modulators
ZA200107630B (en) Cyclocarbamate derivatives as progesterone receptor modulators.
ZA200107633B (en) Cyclothiocarbamate derivatives as progesterone receptor modulators.
UA1593S (uk) Контрацептив вагінальний
ES1044206Y (es) Preservativo vaginal femenino
GB9916989D0 (en) Control of male fertility

Legal Events

Date Code Title Description
HD1A Correction of address
GB1A Change in the ownership or in the address of the owner
HB1A Correction of owner name or address